1.
Disease burden and vaccination priorities in Colombia
by Quitián, Lina María
Vaccine, 2022, Vol.40 (12), p.1717-1721

2.

3.
Hepatitis B virus vaccine in chronic kidney disease: Improved immunogenicity by adjuvants? A meta-analysis of randomized trials
by Fabrizi, Fabrizio
Vaccine, 2012, Vol.30 (13), p.2295-2300

4.
Vaccine administration in children with chronic kidney disease
by Esposito, Susanna
Vaccine, 2014, Vol.32 (49), p.6601-6606

5.
Assessing the cost-utility of preferentially administering Heplisav-B vaccine to certain populations
by Rosenthal, Elizabeth M
Vaccine, 2020, Vol.38 (51), p.8206-8215

6.
Comparative cost-effectiveness of a 2-dose versus 3-dose vaccine for hepatitis B prevention in selected adult populations
by Hirst, Alex
Vaccine, 2021, Vol.39 (33), p.4733-4741

7.
Adverse events following mRNA SARS-CoV-2 vaccination among U.S. nursing home residents
by Bardenheier, Barbara H
Vaccine, 2021, Vol.39 (29), p.3844-3851

8.
Comparative safety of high-dose versus standard-dose influenza vaccination in patients with end-stage renal disease
by Layton, J. Bradley
Vaccine, 2020, Vol.38 (33), p.5178-5186

9.
Hepatitis B vaccination in predialysis chronic renal failure patients a comparison of two vaccination schedules
by McNulty, C.A.M
Vaccine, 2005, Vol.23 (32), p.4142-4147
